MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance.

Virchows Arch · 2016 · PMC5007278 · PMID 27298226

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

showed a trendp = 0.07so close (0.05 < p ≤ 0.1)

High expression of MUC5AC showed a trend toward improved PFS (HR 0.44, 95 % CI 0.18–1.07, p = 0.07), while no association of MMR deficiency with PFS was observed (HR 1.04, 95 % CI 0.49–2.23, p = 0.92).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.